The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives
Abstract Multi-pathway approaches for the treatment of complex polygenic disorders are emerging as alternatives to classical monotarget therapies and microRNAs are of particular interest in that regard. MicroRNA research has come a long way from their initial discovery to the cumulative appreciation...
Main Authors: | Hannah Walgrave, Lujia Zhou, Bart De Strooper, Evgenia Salta |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-11-01
|
Series: | Molecular Neurodegeneration |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13024-021-00496-7 |
Similar Items
-
Recent Advances in the Roles of MicroRNA and MicroRNA-Based Diagnosis in Neurodegenerative Diseases
by: Juan Zhang, et al.
Published: (2022-11-01) -
A new perspective on Alzheimer’s disease: microRNAs and circular RNAs
by: Shahidee Zainal Abidin, et al.
Published: (2023-09-01) -
Common microRNA regulated pathways in Alzheimer’s and Parkinson’s disease
by: Betina Awuson-David, et al.
Published: (2023-09-01) -
Alzheimer’s disease: presence and role of microRNAs
by: Basavaraju Manasa, et al.
Published: (2016-08-01) -
Cerebrospinal fluid microRNAs as potential biomarkers in Alzheimer’s disease
by: Ahmed Noor Eddin, et al.
Published: (2023-07-01)